Treatment of drug-resistant pneumococcal pneumonia
Data up to Jan 2025
Total Citations Per Year
Abstract
References (101)
A Prediction Rule to Identify Low-Risk Patients with Community-Acquired Pneumonia
1997 • 4,477 citations
State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and Men
1998 • 2,792 citations
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
2000 • 2,295 citations
Decreased Susceptibility ofStreptococcus pneumoniaeto Fluoroquinolones in Canada
1999 • 1,012 citations
Pneumococcal Bacteremia with Especial Reference to Bacteremic Pneumococcal Pneumonia
1964 • 947 citations
Antimicrobial Resistance in Streptococcus pneumoniae: An Overview
1992 • 892 citations
Resistance to Penicillin and Cephalosporin and Mortality from Severe Pneumococcal Pneumonia in Barcelona, Spain
1995 • 785 citations
Management of Community-Acquired Pneumonia in the Era of Pneumococcal Resistance
2000 • 629 citations
Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997
2000 • 596 citations
Resistance to Levofloxacin and Failure of Treatment of Pneumococcal Pneumonia
2002 • 536 citations
Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study
1996 • 493 citations
Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae
1996 • 430 citations
A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia
1997 • 367 citations
Failure of Macrolide Antibiotic Treatment in Patients with Bacteremia Due to Erythromycin‐ResistantStreptococcus pneumoniae
2002 • 331 citations
Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 Oral Antimicrobial Agents Based on Pharmacodynamic Parameters: 1997 U.S. Surveillance Study
1999 • 324 citations
Macrolide Resistance Among Invasive <EMPH TYPE="ITAL">Streptococcus pneumoniae</EMPH> Isolates
2001 • 316 citations
Mutant Prevention Concentrations of Fluoroquinolones for Clinical Isolates of Streptococcus pneumoniae
2001 • 312 citations
mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae
1997 • 304 citations
Pharmacodynamics of Fluoroquinolones against Streptococcus pneumoniae in Patients with Community-Acquired Respiratory Tract Infections
2001 • 300 citations
Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence
2002 • 295 citations
Mutations in 23S rRNA and Ribosomal Protein L4 Account for Resistance in Pneumococcal Strains Selected In Vitro by Macrolide Passage
2000 • 283 citations
Impact of Penicillin Susceptibility on Medical Outcomes for Adult Patients with Bacteremic Pneumococcal Pneumonia
2000 • 275 citations
Identification of an Efflux Pump Gene, pmrA , Associated with Fluoroquinolone Resistance in Streptococcus pneumoniae
1999 • 258 citations
Spread of Drug‐ResistantStreptococcus pneumoniaein Asian Countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study
1999 • 256 citations
Trends in Antimicrobial Resistance of Clinical Isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990)
1992 • 254 citations
Two New Mechanisms of Macrolide Resistance in Clinical Strains of Streptococcus pneumoniae from Eastern Europe and North America
2000 • 253 citations
Breakthrough Pneumococcal Bacteremia in Patients Being Treated with Azithromycin and Clarithromycin
2000 • 237 citations
Bacteremic pneumococcal pneumonia in one American city: a 20-year longitudinal study, 1978–1997
1999 • 236 citations
Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000
2001 • 235 citations
Measuring the comparative efficacy of antibacterial agents for acute otitis media: The “Pollyanna phenomenon”
1992 • 228 citations
Predictive Factors for Invasive Disease Due to Penicillin-Resistant Streptococcus pneumoniae: A Population-Based Study
1994 • 227 citations
Risk Factors for Acquisition of Levofloxacin-Resistant Streptococcus pneumoniae: A Case-Control Study
2001 • 217 citations
Antimicrobial Susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes Isolates and Their Ecological Relationships: Results of a 1-Year (1998–1999) Multicenter Surveillance Study in Spain
2001 • 208 citations
Azithromycin: 3-Day Versus 5-Day Course in the Treatment of Respiratory Tract Infections in Children
1997 • 205 citations
Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease
1995 • 202 citations
Antimicrobial Resistance withStreptococcus pneumoniaein the United States, 1997–98
1999 • 188 citations
Prevalence and Characterization of the Mechanisms of Macrolide, Lincosamide, and Streptogramin Resistance in Isolates of Streptococcus pneumoniae
1998 • 180 citations
Streptococcus pneumoniae : molecular biology & mechanisms of disease
2000 • 179 citations
Inhibition of the expression of penicillin resistance in Streptococcus pneumoniae by inactivation of cell wall muropeptide branching genes
2000 • 179 citations
Prevalence of Macrolide Resistance Mechanisms in Streptococcus pneumoniae Isolates from a Multicenter Antibiotic Resistance Surveillance Study Conducted in the United States in 1994-1995
1999 • 177 citations
Contribution of mutations in gyrA and parC genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitro
1996 • 176 citations
Association Between FcγRIIa-R131 Allotype and Bacteremic Pneumococcal Pneumonia
2000 • 172 citations
Antimicrobial Resistance of 1,113 Streptococcus pneumoniae Isolates from Patients with Respiratory Tract Infections in Spain: Results of a 1-Year (1996–1997) Multicenter Surveillance Study
1999 • 170 citations
Survey of Susceptibilities of Streptococcus pneumoniae , Haemophilus influenzae , and Moraxella catarrhalis Isolates to 26 Antimicrobial Agents: a Prospective U.S. Study
1999 • 168 citations
Primary Targets of Fluoroquinolones in Streptococcus pneumoniae
1999 • 166 citations
Penicillin Resistance and Other Predictors of Mortality in Pneumococcal Bacteremia in a Population with High Human Immunodeficiency Virus Seroprevalence
1999 • 159 citations
Prevalence of gyrA , gyrB , parC , and parE Mutations in Clinical Isolates of Streptococcus pneumoniae with Decreased Susceptibilities to Different Fluoroquinolones and Originating from Worldwide Surveillance Studies during the 1997-1998 Respiratory Season
2000 • 156 citations
Risk Factors and Course of Illness Among Children With Invasive Penicillin-resistant Streptococcus pneumoniae
1999 • 150 citations
A biological price of antibiotic resistance: major changes in the peptidoglycan structure of penicillin-resistant pneumococci.
1990 • 146 citations
In Vitro and In Vivo Antimicrobial Activities of T-3811ME, a Novel Des-F(6)-Quinolone
1999 • 146 citations
Clinical Outcomes of Bacteremic Pneumococcal Pneumonia in the Era of Antibiotic Resistance
2001 • 145 citations
Susceptibilities of Penicillin- and Erythromycin-Susceptible and -Resistant Pneumococci to HMR 3647 (RU 66647), a New Ketolide, Compared with Susceptibilities to 17 Other Agents
1998 • 140 citations
Bacteremic Pneumonia Due to Multidrug-Resistant Pneumococci in 3 Patients Treated Unsuccessfully with Azithromycin and Successfully with Levofloxacin
2000 • 134 citations
Characterization of a mutation in the parE gene that confers fluoroquinolone resistance in Streptococcus pneumoniae
1997 • 131 citations
Antimicrobial Use and the Emergence of Antimicrobial Resistance withStreptococcus pneumoniaein the United States
2001 • 130 citations
Fluoroquinolone Resistance in Clinical Isolates of Streptococcus pneumoniae : Contributions of Type II Topoisomerase Mutations and Efflux to Levels of Resistance
2000 • 122 citations
Mutation in 23S rRNA Responsible for Resistance to 16-Membered Macrolides and Streptogramins in Streptococcus pneumoniae
2001 • 122 citations
A Comparative Study of Levofloxacin and Ceftriaxone in the Treatment of Hospitalized Patients with Pneumonia
1998 • 119 citations
Inappropriate Use of Oral Ciprofloxacin
1990 • 110 citations
Patterns of Macrolide Resistance Determinants among Community-Acquired Streptococcus pneumoniae Isolates over a 5-Year Period of Decreased Macrolide Susceptibility Rates
1999 • 96 citations
Selection of Streptococcus pneumoniae Mutants Having Reduced Susceptibility to Moxifloxacin and Levofloxacin
2002 • 96 citations
Antipneumococcal Activities of Gemifloxacin Compared to Those of Nine Other Agents
2000 • 90 citations
Pneumonia Caused by Penicillin-non-susceptible and Penicillin-susceptible Pneumococci in Adults: A Case-Control Study
1998 • 86 citations
Extremely High Incidence of Macrolide and Trimethoprim-Sulfamethoxazole Resistance among Clinical Isolates of Streptococcus pneumoniae in Taiwan
1999 • 84 citations
Susceptibilities to Telithromycin and Six Other Agents and Prevalence of Macrolide Resistance Due to L4 Ribosomal Protein Mutation among 992 Pneumococci from 10 Central and Eastern European Countries
2002 • 82 citations
Invasive Candidiasis: Turning Risk into a Practical Prevention Policy?
2001 • 79 citations
Pneumococcal bacteremia during Ciprofloxacin therapy for pneumococcal pneumonia
1989 • 77 citations
Japanese guidelines for the management of community-acquired pneumonia
2001 • 75 citations
Pharmacodynamic Assessment of Clarithromycin in a Murine Model of Pneumococcal Pneumonia
2002 • 74 citations
PNEUMOCOCCUS RESISTANT TO ERYTHROMYCIN AND LINCOMYCIN
1967 • 73 citations
Breakthrough Sepsis in Macrolide-Resistant Pneumococcal Infection
1996 • 71 citations
In Vitro Exchange of Fluoroquinolone Resistance Determinants betweenStreptococcus pneumoniaeand Viridans Streptococci and Genomic Organization of theparE‐parCRegion inS. mitis
1999 • 71 citations
Prevalence of Single Mutations in Topoisomerase Type II Genes among Levofloxacin-Susceptible Clinical Strains of Streptococcus pneumoniae Isolated in the United States in 1992 to 1996 and 1999 to 2000
2002 • 66 citations
Relationship between Capsular Type, Penicillin Susceptibility, and Virulence of Human Streptococcus pneumoniae Isolates in Mice
2000 • 63 citations
Superinfection with Streptococcus pneumoniae during therapy with ciprofloxacin
1990 • 61 citations
Emergence in France of Multiple Clones of Clinical Streptococcus pneumoniae Isolates with High-Level Resistance to Amoxicillin
1999 • 51 citations
Comparison of Pharmacodynamics of Azithromycin and Erythromycin In Vitro and In Vivo
1998 • 51 citations
In Vitro Selection of Resistance to Clinafloxacin, Ciprofloxacin, and Trovafloxacin in Streptococcus pneumoniae
2000 • 49 citations
Synergy between amoxicillin and gentamicin in combination against a highly penicillin-resistant and -tolerant strain of Streptococcus pneumoniae in a mouse pneumonia model
1996 • 46 citations
Distribution of Streptococcus pneumoniae resistant to penicillin in the USA and in-vitro susceptibility to selected oral antibiotics
1995 • 44 citations
Ciprofloxacin in acute exacerbations of chronic bronchitis
1986 • 44 citations
Impact of Antibiotic Resistance on Chemotherapy for Pneumococcal Infections
1998 • 44 citations
Fatal Meningitis Due to Levofloxacin-Resistant Streptococcus pneumoniae
1999 • 44 citations
PNEUMOCOCCAL MENINGITIS DURING THERAPY OF OTITIS MEDIA WITH CLARITHROMYCIN
1995 • 38 citations
Efficacy of High-Dose Amoxicillin-Clavulanate against Experimental Respiratory Tract Infections Caused by Strains of Streptococcus pneumoniae
1999 • 38 citations
Microbiological and Pharmacodynamic Considerations in the Treatment of Infection Due to Antimicrobial-Resistant Streptococcus pneumoniae
2000 • 32 citations
Efficacy of beta-lactam antibiotics combined with gentamicin against penicillin-resistant pneumococcal pneumonia in CBA/J mice
1999 • 32 citations
Comparative in vitro potency of gemifloxacin against European respiratory tract pathogens isolated in the Alexander Project
2000 • 31 citations
The epidemiology of penicillin resistance in Streptococcus pneumoniae.
1999 • 29 citations
Antimicrobial activities of beta-lactam antibiotics and gentamicin against penicillin-susceptible and penicillin-resistant pneumococci
1995 • 25 citations
Treatment of Pneumococcal Pneumonia
1941 • 21 citations
Susceptibility of Streptococcus pneumoniae and Haemophilus influenzae to cefditoren, and provisional interpretive criteria
2000 • 21 citations
Will pneumococci put quinolones in their place?
1999 • 20 citations
Activities of oral and parenteral agents against penicillin-susceptible and -resistant pneumococci
1995 • 19 citations
In-vitro killing activity of combinations of beta-lactam agents with aminoglycosides against penicillin-resistant pneumococci
1997 • 14 citations
Treatment of pneumococcal pneumonia: the case for penicillin G
1999 • 13 citations
Fluoroquinolone Resistance in
1999 • 12 citations
In vivo activity and pharmacodynamics of amoxicillin in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae
1996 • 11 citations
Assessing the Quality of the Alexander Project
1999 • 11 citations
Treatment of Pneumococcal Pneumonia
1964 • 7 citations
Reply
2000 • 1 citations